Fibrin: a natural biodegradable scaffold in vascular tissue engineering
- PMID: 18552484
- DOI: 10.1159/000139772
Fibrin: a natural biodegradable scaffold in vascular tissue engineering
Abstract
Arterial occlusive disease remains a major health issue in the developed world and a rapidly growing problem in the developing world. Although a growing number of patients are now being effectively treated with minimally invasive techniques, there remains a tremendous pressure on the vascular community to develop a synthetic small-diameter vascular graft with improved long-term patency rates. The field of tissue engineering offers an exciting alternative in the search for living organ replacement structures. Several methodologies have emerged for constructing blood vessel replacements with biological functionality. Common strategies include cell-seeded biodegradable synthetic scaffolds, cell self-assembly, cell-seeded gels and xenogeneic acellular materials. A wide range of materials are being investigated as potential scaffolds for vascular tissue engineering applications. Some are commercialised and others are still in development. Recently, researchers have studied the role of fibrin gel as a three-dimensional scaffold in vascular tissue engineering. This overview describes the properties of fibrin gel in vascular tissue engineering and highlights some recent progress and difficulties encountered in the development of cell fibrin scaffold technology.
Copyright 2008 S. Karger AG, Basel.
Similar articles
-
Autologous blood vessels engineered from peripheral blood sample.Eur J Vasc Endovasc Surg. 2007 Jan;33(1):33-9. doi: 10.1016/j.ejvs.2006.08.008. Epub 2006 Oct 25. Eur J Vasc Endovasc Surg. 2007. PMID: 17070080
-
Tissue-engineered blood vessel graft produced by self-derived cells and allogenic acellular matrix: a functional performance and histologic study.Ann Plast Surg. 2009 Mar;62(3):297-303. doi: 10.1097/SAP.0b013e318197eb19. Ann Plast Surg. 2009. PMID: 19240529
-
Vascular tissue generation in response to signaling molecules integrated with a novel poly(epsilon-caprolactone)-fibrin hybrid scaffold.J Tissue Eng Regen Med. 2007 Sep-Oct;1(5):389-97. doi: 10.1002/term.48. J Tissue Eng Regen Med. 2007. PMID: 18038433
-
[Progress on scaffold of vascular tissue engineering].Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2009 Sep;23(9):1134-7. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2009. PMID: 19817305 Review. Chinese.
-
Advancing vascular tissue engineering: the role of stem cell technology.Trends Biotechnol. 2005 Sep;23(9):461-7. doi: 10.1016/j.tibtech.2005.06.006. Trends Biotechnol. 2005. PMID: 15979750 Review.
Cited by
-
Spatiotemporal control of vascular endothelial growth factor expression using a heat-shock-activated, rapamycin-dependent gene switch.Hum Gene Ther Methods. 2013 Jun;24(3):160-70. doi: 10.1089/hgtb.2013.026. Epub 2013 May 6. Hum Gene Ther Methods. 2013. PMID: 23527589 Free PMC article.
-
An Investigation of the Constructional Design Components Affecting the Mechanical Response and Cellular Activity of Electrospun Vascular Grafts.Membranes (Basel). 2022 Sep 25;12(10):929. doi: 10.3390/membranes12100929. Membranes (Basel). 2022. PMID: 36295688 Free PMC article. Review.
-
Bioengineered three-dimensional physiological model of colonic longitudinal smooth muscle in vitro.Tissue Eng Part C Methods. 2010 Oct;16(5):999-1009. doi: 10.1089/ten.TEC.2009.0394. Tissue Eng Part C Methods. 2010. PMID: 20001822 Free PMC article.
-
In vitro and in vivo assessment of controlled release and degradation of acoustically responsive scaffolds.Acta Biomater. 2016 Dec;46:221-233. doi: 10.1016/j.actbio.2016.09.026. Epub 2016 Sep 27. Acta Biomater. 2016. PMID: 27686040 Free PMC article.
-
Regenerative medicine, tissue engineering and vascular surgery: twenty first century clinical challenges.Ir J Med Sci. 2010 Mar;179(1):1-2. doi: 10.1007/s11845-009-0457-7. Epub 2009 Dec 9. Ir J Med Sci. 2010. PMID: 20012225 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources